February 6, 2026
Weill Cornell Medicine is part of an international team that has been awarded funding of up to $25 million over five years by Cancer Grand Challenges to study the causes of cancer inequities.
Dr. Olivier Elemento serves as Principal Investigator on SAMBAI (Societal, Ancestry and Molecular Biology Analyses of Inequalities), a National Cancer Institute-funded project running from 2024-2026 that aims to understand why cancer outcomes differ across populations.
This major initiative reflects the lab's commitment to addressing health disparities through rigorous scientific investigation, combining computational approaches with biological and social determinants of health.